Skip to main content
. 2017 Nov 14;8:1482. doi: 10.1038/s41467-017-01386-7

Fig. 5.

Fig. 5

Synergistic in vitro immunostimulation of iDR-NC nanoadjuvants. a Real-time quantitative RT-PCR results showing Stat3 silencing in DC2.4 cells treated with iDR-NCs for 48 h. Stat3 siRNA and scramble served as controls. b Flow cytometry results showing that p-STAT3 expression was down-regulated in DC2.4 cells treated with iDR-NCs for 48 h. STAT3 inhibitor (Sttatic) and Lipofectamine2000-transfected Stat3 siRNA were used as controls. Stat3 shRNA: 100 nM equivalents in a, b. c Flow cytometry results showing that iDR-NCs (100 nM CpG equivalents) elevated the expression of costimulatory factor CD80 in DC2.4 cells after 24 h. d ELISA results suggest iDR-NCs (200 nM CpG equivalents) induced DC2.4 cells to secrete significantly more TNFα, IL-6, and IL-12p40 than CpG or CpG MFs, after 24 h. Stat3 siRNA alone was used as a control. (ns: non-significant; *p < 0.05; **p < 0.01; n = 3; one-way ANOVA with Bonferroni post-hoc test). Data represented as mean ± s.e.m.

HHS Vulnerability Disclosure